AHA Science (@AHAScience) header
AHA Science (@AHAScience) profile picture

@American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.

Dallas, TX
Joined January 2009
In case you missed it, here are all late breaking clinical trial results from #ScientificSessions26.
3
51
142
9,957
Pediatric heart failure (HF) arises from structural or functional cardiac disorders that impair ventricular filling and/or ejection. It is a complex condition with heterogeneous presentations driven by diverse etiologies and is associated with substantial morbidity, mortality, and health care burden. Guideline-directed medical therapy, including angiotensin receptor–neprilysin inhibitors (ARNIs), sodium–glucose cotransporter 2 inhibitors (SGLT2i), and intravenous iron, remains under-investigated in children and are inconsistently prescribed, often requiring clinicians to extrapolate from adult data or practice without formal guidance. This science advisory details results from a survey of pediatric HF clinicians in the United States and Canada, focusing on prescribing practices, side effects, dosing experience, and clinician perspectives on the use of ARNIs, SGLT2i, and iron replacement therapy in children. Read the paper and supplemental materials here: professional.heart.org/en/sc…
2
3
16
1,746
The 2026 Guideline for Adult Stroke Rehabilitation and Recovery was recently published. Here are the top things for occupational therapists to know. View the paper and supplemental resources here: professional.heart.org/en/sc…
1
34
2
86
5,771
Peripheral Artery Disease in Acute Care Settings: Diagnosis and Management of Common Presentations and Emergencies: A Scientific Statement From the American Heart Association: @AHAScience @CircAHA 🥸Congratulations to Dr Rymer and Dr Secemsky on great synthesis 😱Summary is below 👇👇👇
2
18
49
3,604
AHA Science retweeted
Full interview and audience questions link erictopol.substack.com/p/jo-…
1
8
19
12,999
⏰ Time's almost up! We’re looking to fund innovative, high-impact research that could lead to critical discoveries or major advancements in cardiovascular and/or cerebrovascular research. Find out more. 👇 Learn about this opportunity here: bit.ly/4zxdl76
2
5
1,613
Don't miss this chance to jumpstart your research career. If you’re in the early years of your first professional appointment, this grant will support your research, training and mentorship to ensure your future success as a research scientist. Find more information on this opportunity here: bit.ly/4jr4DTi
3
14
2,390
Heart and brain health are deeply connected. Join us Wednesday, Nov. 18 for Blood Pressure: From Science to Social Impact, the first installment of the Heart-Brain Connection Webinar Series. Together, we'll explore perspectives from research, healthcare and community action to turn knowledge into impact. @ycommodore , @dralishareed
3
7
23
2,098
US Veterans make up more than 5% of the US adult population. Compared with the general US population, Veterans are older, have more comorbidities, and face unique structural barriers, including high rates of rural location and less internet access. With time, the makeup of Veterans is becoming increasingly diverse in race, ethnicity, age, gender, and military exposure history. Veterans receiving care in the Veterans Administration (VA) have higher rates of obesity, diabetes, hyperlipidemia, hypertension, and sleep disorders compared to the general population. Data from the Million Veteran Program show that fewer than 5% of Veterans achieve optimal cardiovascular health based on the American Heart Association’s Life’s Essential 8 domains, which in turn has been associated with reduced life expectancy. ✍🏼 @yuanneal @AIDALMARZOOQ @wccushman @jenmartinsleeps @Lisa_Jackson_MD 📷 Meeting the cardiovascular health promotion needs of US veterans: challenges and responses. professional.heart.org/en/sc…
4
5
15
1,850
Patients with CKM syndrome often have multiple conditions requiring care from several clinicians, which can lead to fragmentation of care. Incorporating clinical input from multiple disciplines within the CKM framework and coordinating care among team members are essential components of holistic CKM care. The need for a point person is emphasized, to coordinate efforts of the CKM interdis¬ciplinary team, to facilitate implementation of evidence-based care and guideline-directed medical therapy and to support patients and clinicians. professional.heart.org/en/sc… ✍🏼 @ChiadiNdumele @HeartDocSadiya @kardiologykazi @noshreza @virani_md @biykemb @NutritionHF @mandeepbajaj65 @KatherineTuttl8 @RangaswJ @lisaVWMD @KBreathettMD @EmoryFamMed @ShoaClarke @mad_sters @jmortonmd @sripalbangalore @AnumSaeedMD
3
6
23
1,939
AI is transforming cardiovascular care at the point of care, creating new opportunities to close the gap between scientific discovery and patient care. At #ScientificSessions26, past American Heart Association President Bob Harrington, MD, FAHA and OpenAI's Nate Gross, MD, explored how AI can help accelerate the future of medicine. 💡 @HeartBobH, @NG
2
7
19
1,538
As #ScientificSessions26 comes to a close, we celebrate the science, innovation and collaboration that continue to shape the future of cardiovascular and brain health. Now, we look ahead to a historic milestone. Join us in Boston for the 100th Scientific Sessions, Nov. 5-8, 2027. @HeartDocSadiya @bnallamo #ScientificSessions27
1
12
2
37
3,090
Replying to @AnastasiaSMihai
@AnastasiaSMihai discusses late breaking science from ATTAIN-OSA at #ScientificSessions26. 🎥
1
7
1
22
2,193
Replying to @mirvatalasnag
@mirvatalasnag discusses late breaking science from SYNCHRONIZE-CVOT at #ScientificSessions26. 🎥
2
11
1
26
3,129
SYNCHRONIZE-CVOT results presented at #ScientificSessions26 In adults with obesity and established cardiovascular or chronic kidney disease, or increased cardiovascular risk, survodutide was non-inferior to placebo for a composite of cardiovascular death, non-fatal cardiovascular events, coronary revascularization, and heart failure events, while also improving cardiometabolic markers.
3
6
440
SYNCHRONIZE-CVOT results presented at #ScientificSessions26 In adults with obesity and established cardiovascular or chronic kidney disease, or increased cardiovascular risk, survodutide was non-inferior to placebo for a composite of cardiovascular death, non-fatal cardiovascular events, coronary revascularization, and heart failure events, while also improving cardiometabolic markers.
3
8
1
11
1,689
ATTAIN-OSA results presented at #ScientificSessions26 Among adults with moderate-to-severe OSA and overweight or obesity without diabetes, orforglipron significantly reduced apnea-hypopnea index compared with placebo at 52 weeks, both in participants using and not using positive airway pressure therapy.
1
1
1
3
1,194
ATTAIN-OSA results presented at #ScientificSessions26 Among adults with moderate-to-severe OSA and overweight or obesity without diabetes, orforglipron significantly reduced apnea-hypopnea index compared with placebo at 52 weeks, both in participants using and not using positive airway pressure therapy.
2
8
1
26
2,610
RACE-CARS results presented at #ScientificSessions26 Compared with usual care, the multifaceted intervention did not result in a greater percentage of patients who survived to hospital discharge with a favorable neurologic outcome.
1
1
492